Arcturus Therapeutics Holdings Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $88.39 | $2.72 B | -49.3 | 130 | $110.32 M |
 AKRO
|
Akero Therapeutics, Inc. | $29.55 | $1.59 B | -7.1 | 60 | $0 |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $5.30 | $120.37 M | -1.65 | 384 | $380.79 M |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $2.51 | $291.95 M | -3.13 | 54 | $0 |
 BEAM
|
Beam Therapeutics Inc. | $24.11 | $1.91 B | -14.51 | 472 | $377.71 M |
 BMEA
|
Biomea Fusion, Inc. | $6.43 | $148.81 M | -1.17 | 107 | $0 |
 BPMC
|
Blueprint Medicines Corporation | $90.23 | $6.47 B | -21.48 | 638 | $249.38 M |
 CRBU
|
Caribou Biosciences, Inc. | $1.99 | $176.12 M | -1.41 | 158 | $34.48 M |
 CRSP
|
CRISPR Therapeutics AG | $47.29 | $4.91 B | -21.43 | 407 | $371.21 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.00 | $1.12 B | -5.11 | 174 | $0 |
 ETNB
|
89bio, Inc. | $7.98 | $796.91 M | -4.05 | 70 | $0 |
 FATE
|
Fate Therapeutics, Inc. | $2.28 | $418.90 M | -1.92 | 181 | $63.53 M |
 FDMT
|
4D Molecular Therapeutics, Inc. | $8.31 | $1.17 B | -9.63 | 147 | $20.72 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GOSS
|
Gossamer Bio, Inc. | $0.72 | $124.06 M | -0.65 | 135 | $0 |
 ISEE
|
IVERIC bio, Inc. | $39.95 | $5.51 B | -22.44 | 163 | $0 |
 KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $303.59 | $5.21 B | -10.55 | 376 | $0 |
 NTLA
|
Intellia Therapeutics, Inc. | $14.17 | $2.19 B | -4.23 | 526 | $36.28 M |
 PLRX
|
Pliant Therapeutics, Inc. | $12.32 | $672.63 M | -3.9 | 166 | $1.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $11.89 | $774.50 M | -6.14 | 110 | $8.78 M |